<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03225456</url>
  </required_header>
  <id_info>
    <org_study_id>IG15-LR052</org_study_id>
    <nct_id>NCT03225456</nct_id>
  </id_info>
  <brief_title>Oxytocin and Eating</brief_title>
  <official_title>Exploring the Effects of Oxytocin on Appetite Regulation in Healthy Adult Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale-NUS College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Singapore General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SingHealth Investigational Medicine Unit</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale-NUS College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this protocol, the investigators propose a randomised controlled trial to explore the
      effects of intra-nasal oxytocin administration on appetite regulation. The investigators will
      run a cross-over design with 60 healthy adult men.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2017</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Taste sensitivity</measure>
    <time_frame>2-hour span following oxytocin administration</time_frame>
    <description>Taste thresholds for primary taste senses, measured using psychophysical staircase procedures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Taste preference</measure>
    <time_frame>2-hour span following oxytocin administration</time_frame>
    <description>Measured using the positive/negative generalised Labeled Magnitude Scale used to
assess pleasantness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Value placed upon food</measure>
    <time_frame>2-hour span following oxytocin administration</time_frame>
    <description>Willingness to pay for food (vs non-food items) in a Becker-DeGroot-Marschak auction task</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective ratings of hunger and fullness</measure>
    <time_frame>2-hour span following oxytocin administration</time_frame>
    <description>Measured using 100-point Visual Analogue Scales</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Weight Gain</condition>
  <arm_group>
    <arm_group_label>Oxytocin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive two doses of 24 IU intra-nasal oxytocin (Syntocinon) in a single session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will received match placebo, again in two doses in a single session</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Syntocinon</intervention_name>
    <description>Intra-nasal oxytocin</description>
    <arm_group_label>Oxytocin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>Intra-nasal placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gender: Male

          -  Age: 21-45 years

          -  Normal weight: Body mass index of 18.5 to 22.9

          -  Have had a stable weight for the past 3 months (less than 5kg)

          -  Have regular breakfast meals (â‰¥ 4 times a week of self-reported consumption of a
             breakfast meal)

          -  Have habitual sleep of 6.5-8.5 hours

          -  Have English as first language (or fluent in spoken and written English)

        Exclusion Criteria:

          -  Symptoms / history of any major medical condition, including:

               -  Bariatric surgery or surgical obesity treatment

               -  Diabetes

               -  Cardiovascular disease

               -  Thyroid disease

               -  Anaemia

               -  Psychiatric disorders

               -  Eating disorders

          -  Excessive exercise (running &gt; 40 km or exercising &gt; 10 hr in a week)

          -  Currently on a special diet or trying deliberately to restrict food intake

          -  Currently on a weight loss program

          -  Smoking or substance abuse

          -  Use of medications that can affect weight (e.g., steroids, approved weight-loss drugs)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Yale-NUS College</name>
      <address>
        <city>Singapore</city>
        <zip>138527</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2017</study_first_submitted>
  <study_first_submitted_qc>July 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2017</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>appetite regulation</keyword>
  <keyword>obesity</keyword>
  <keyword>oxytocin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Gain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

